Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

OBJECTIVE: FX006 is a novel, microsphere‐based, extended‐release formulation of triamcinolone acetonide for intraarticular (IA) injection designed to maintain treatment concentration in the joint and provide prolonged analgesic benefits in patients with osteoarthritis (OA) of the knee. This study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Conaghan, Philip G., Cohen, Stanley B., Berenbaum, Francis, Lufkin, Joelle, Johnson, James R., Bodick, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Osteoarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814922/
https://www.ncbi.nlm.nih.gov/pubmed/29088579
http://dx.doi.org/10.1002/art.40364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814922/
https://www.ncbi.nlm.nih.gov/pubmed/29088579
http://dx.doi.org/10.1002/art.40364

Ejemplares similares